Platelets and coronary intervention: some practical precautions

J Invasive Cardiol. 2000 Oct;12(10):536-8.
No abstract available

Publication types

  • Comment

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Coronary Disease / drug therapy*
  • Drug Monitoring
  • Eptifibatide
  • Female
  • Humans
  • Immunoglobulin Fab Fragments / adverse effects
  • Immunoglobulin Fab Fragments / therapeutic use
  • Incidence
  • Male
  • Peptides / adverse effects
  • Peptides / therapeutic use
  • Platelet Aggregation Inhibitors / adverse effects*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Prognosis
  • Risk Assessment
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / epidemiology
  • Tirofiban
  • Tyrosine / adverse effects
  • Tyrosine / analogs & derivatives
  • Tyrosine / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Peptides
  • Platelet Aggregation Inhibitors
  • Tyrosine
  • Tirofiban
  • Eptifibatide
  • Abciximab